These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10202635)

  • 1. [The role of a systemic inflammatory process in the atherogenic modification of lipoproteins and the development of hypercholesterolemia].
    Bratus' VV; Talaieva TV; Radalovs'ka NV; Tretiak IV
    Fiziol Zh (1994); 1999; 45(1-2):40-9. PubMed ID: 10202635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic inflammatory process as an etiological factor in increase of atherogenic potential of plasma].
    Ruban NV
    Fiziol Zh (1994); 2004; 50(2):64-74. PubMed ID: 15174207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modified lipoproteins--their types and role in atherogenesis].
    Bratus' VV; Talaieva TV; Lomakovs'kyĭ OM; Tretiak IV; Radalovs'ka NV
    Fiziol Zh (1994); 2000; 46(2):73-81. PubMed ID: 10867865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrygliceridemia as a factor of atherogenesis: significance and mechanisms of action].
    Ambroskina VV; Kriachok TA; Larionov OP; Bratus' VV; Talaieva TV
    Fiziol Zh (1994); 2008; 54(5):61-70. PubMed ID: 19058514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperlipidemia and decrease of lipid tolerance as factors of atherogenesis].
    Ambroskina VV; Kriachok TA; Larionov OP; Talaieva TV; Bratus' VV
    Fiziol Zh (1994); 2007; 53(6):19-28. PubMed ID: 18309627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The presence and characteristics of interrelations between lipid metabolism disorder and systemic inflammation].
    Ambroskina VV; Kriachok TA; Larionov OP; Bratus' VV; Talaieva TV
    Fiziol Zh (1994); 2008; 54(3):36-46. PubMed ID: 18763578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The vasoactive properties of different classes of blood lipoproteins in hypercholesterolemia and atherosclerosis].
    Frol'kis VV; Kul'chitskiĭ OK; Novikova SN; Sykalo NV; Potapenko RI; Mozzhukhina TG; Bogatskaia LN; Burchinskaia MK
    Patol Fiziol Eksp Ter; 2000; (1):15-7. PubMed ID: 10741181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indices of lipid peroxidation and atherogenic blood lipoproteins in patients with coronary heart disease receiving antioxidants in addition to basic therapy].
    Reĭzin AB; Tel'nykh IuV
    Klin Med (Mosk); 2005; 83(11):63-4. PubMed ID: 16404943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
    Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
    Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of lipoprotein modification in atherogenesis (review)].
    Shpikiter VO
    Vopr Med Khim; 1987; 33(4):2-8. PubMed ID: 3310395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?
    Stokes KY; Granger DN
    J Physiol; 2005 Feb; 562(Pt 3):647-53. PubMed ID: 15611017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein (a)--a mysterious factor in atherogenesis].
    Jelaković B; Laganović M; Kuzmanić D
    Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
    Deepa PR; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
    Moriel P; Okawabata FS; Abdalla DS
    IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic modulation of inflammation-induced activation of coagulation.
    Levi M; Nieuwdorp M; van der Poll T; Stroes E
    Semin Thromb Hemost; 2008 Feb; 34(1):26-32. PubMed ID: 18393140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
    Hurt-Camejo E; Camejo G
    Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assay for plasma soluble E-selectin predicts the development of acute respiratory distress syndrome in patients with systemic inflammatory response syndrome.
    Okajima K; Harada N; Sakurai G; Soga Y; Suga H; Terada T; Nakagawa T
    Transl Res; 2006 Dec; 148(6):295-300. PubMed ID: 17162250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory processes.
    Duarte MM; Loro VL; Rocha JB; Leal DB; Bem AF; Dorneles A; Morsch VM; Schetinger MR
    FEBS J; 2007 Jun; 274(11):2707-14. PubMed ID: 17451439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ischemic cardiopathy: risk factors and their biological role].
    Mancini M; Rubba P
    Ital Heart J; 2000 Jun; 1 Suppl 2():17-22. PubMed ID: 10905124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in acute pancreatitis.
    Schulz HU; Niederau C; Klonowski-Stumpe H; Halangk W; Luthen R; Lippert H
    Hepatogastroenterology; 1999; 46(29):2736-50. PubMed ID: 10576339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.